Camtek (CAMT) Competitors $87.52 +5.48 (+6.68%) Closing price 04:00 PM EasternExtended Trading$88.76 +1.24 (+1.42%) As of 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CAMT vs. RVTY, AVTR, NVMI, BIO.B, VNT, MIR, ST, TXG, TRNS, and ALNTShould you be buying Camtek stock or one of its competitors? The main competitors of Camtek include Revvity (RVTY), Avantor (AVTR), Nova (NVMI), Bio-Rad Laboratories (BIO.B), Vontier (VNT), Mirion Technologies (MIR), Sensata Technologies (ST), 10x Genomics (TXG), Transcat (TRNS), and Allient (ALNT). These companies are all part of the "measuring and control equipment" industry. Camtek vs. Its Competitors Revvity Avantor Nova Bio-Rad Laboratories Vontier Mirion Technologies Sensata Technologies 10x Genomics Transcat Allient Camtek (NASDAQ:CAMT) and Revvity (NYSE:RVTY) are both measuring and control equipment companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk. Do analysts rate CAMT or RVTY? Camtek currently has a consensus price target of $89.70, indicating a potential upside of 2.49%. Revvity has a consensus price target of $123.64, indicating a potential upside of 22.54%. Given Revvity's higher possible upside, analysts clearly believe Revvity is more favorable than Camtek.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Camtek 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.00Revvity 0 Sell rating(s) 4 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.80 Is CAMT or RVTY more profitable? Camtek has a net margin of 28.40% compared to Revvity's net margin of 10.35%. Camtek's return on equity of 24.57% beat Revvity's return on equity.Company Net Margins Return on Equity Return on Assets Camtek28.40% 24.57% 15.09% Revvity 10.35%7.73%4.72% Which has more volatility and risk, CAMT or RVTY? Camtek has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500. Comparatively, Revvity has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500. Does the media prefer CAMT or RVTY? In the previous week, Revvity had 5 more articles in the media than Camtek. MarketBeat recorded 13 mentions for Revvity and 8 mentions for Camtek. Camtek's average media sentiment score of 0.99 beat Revvity's score of -0.07 indicating that Camtek is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Camtek 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Revvity 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Do insiders and institutionals believe in CAMT or RVTY? 41.9% of Camtek shares are owned by institutional investors. Comparatively, 86.7% of Revvity shares are owned by institutional investors. 79.4% of Camtek shares are owned by insiders. Comparatively, 0.7% of Revvity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has higher earnings and valuation, CAMT or RVTY? Revvity has higher revenue and earnings than Camtek. Camtek is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCamtek$429.23M9.30$118.51M$2.6133.53Revvity$2.76B4.32$270.39M$2.3542.94 SummaryCamtek beats Revvity on 9 of the 16 factors compared between the two stocks. Get Camtek News Delivered to You Automatically Sign up to receive the latest news and ratings for CAMT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CAMT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CAMT vs. The Competition Export to ExcelMetricCamtekELEC MSRNG INST IndustryComputer SectorNASDAQ ExchangeMarket Cap$3.74B$14.43B$27.19B$8.87BDividend YieldN/A0.28%3.15%4.10%P/E Ratio33.5325.3236.0419.90Price / Sales9.305.672,037.69113.66Price / Cash27.5022.6637.6556.90Price / Book7.245.897.055.38Net Income$118.51M$303.71M$763.02M$248.50M7 Day Performance6.61%4.23%3.10%2.97%1 Month Performance31.00%41.68%6.51%6.02%1 Year Performance-31.27%27.16%52,212.28%20.39% Camtek Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CAMTCamtek3.0059 of 5 stars$87.52+6.7%$89.70+2.5%-35.8%$3.74B$429.23M33.53400Analyst ForecastGap UpRVTYRevvity3.7443 of 5 stars$95.01+0.0%$125.64+32.2%-3.9%$11.20B$2.76B40.4311,000AVTRAvantor4.9845 of 5 stars$13.45-0.9%$18.88+40.3%-33.0%$9.17B$6.78B12.9313,500Positive NewsNVMINova2.0267 of 5 stars$234.10+1.3%$277.00+18.3%+15.3%$6.88B$672.40M35.364,149Positive NewsBIO.BBio-Rad LaboratoriesN/A$250.08flatN/A-11.8%$6.80B$2.57B-3.288,200VNTVontier3.6268 of 5 stars$36.28+1.5%$44.83+23.6%-1.1%$5.37B$2.96B14.758,000MIRMirion Technologies0.7315 of 5 stars$20.33+3.5%$18.75-7.8%+93.2%$4.72B$860.80M-338.832,860High Trading VolumeSTSensata Technologies4.222 of 5 stars$28.63+1.3%$34.08+19.0%-16.7%$4.19B$3.93B35.3519,000News CoverageAnalyst ForecastTXG10x Genomics4.645 of 5 stars$10.79-0.2%$15.81+46.5%-35.1%$1.33B$610.78M-8.301,240TRNSTranscat2.9649 of 5 stars$80.27-0.3%$114.00+42.0%-26.9%$748.12M$278.42M51.461,245ALNTAllient2.674 of 5 stars$34.61+2.6%$31.00-10.4%+50.5%$585.95M$529.97M58.662,525News Coverage Related Companies and Tools Related Companies Revvity Alternatives Avantor Alternatives Nova Alternatives Bio-Rad Laboratories Alternatives Vontier Alternatives Mirion Technologies Alternatives Sensata Technologies Alternatives 10x Genomics Alternatives Transcat Alternatives Allient Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CAMT) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Camtek Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Camtek With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.